Craig Tendler, M.D., JNJ's Former Global Head of Oncology Clinical Development, to Lead TuHURA Bioscience's VISTA Program in AML and other Blood Related Cancers [Yahoo! Finance]
Craig Tendler, M.D., JNJ's Former Global Head of Oncology Clinical Development, to Lead TuHURA Bioscience's VISTA Program in AML and other Blood Related Cancers
TuHURA Biosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement [Yahoo! Finance]
TuHURA Biosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement